11357955|t|Intron 7 retention and exon 9 skipping EAAT2 mRNA variants are not associated with amyotrophic lateral sclerosis.
11357955|a|Glutamate-mediated excitotoxicity is implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). The astroglial glutamate transporter EAAT2 plays a major role in maintaining low levels of extracellular glutamate in the central nervous system. Multiple EAAT2 mRNA transcripts have been described, but those retaining intron 7 or skipping exon 9 are reported to be specific to the motor cortex, spinal cord, and cerebrospinal fluid of ALS patients. We sought to verify these findings using a TaqMan (Elmer Biosystems, Warrington, UK) real-time reverse transcriptase polymerase chain reaction assay, which provides a sensitive and reliable quantitative measure of EAAT2 transcript copy ratios. We analyzed RNA extracted from frozen postmortem tissue from affected and unaffected central nervous system regions dissected from 17 sporadic ALS patients, 7 Alzheimer's disease patients, and 19 control subjects. We have demonstrated unequivocally that intron 7 retaining and exon 9 skipping variants can be detected in all individuals and in all central nervous system regions studied. The mean ratio of "variant" to "normal" transcripts did not differ significantly between patient and control groups. Although our assay could detect transcript concentrations in cerebrospinal fluid as low as 10 pg/ml, none were detected in 17 ALS and 8 control samples. We conclude that ALS is not associated with elevated levels of EAAT2 transcripts retaining intron 7 and skipping exon 9. An alternative explanation must be sought for the disturbance of glutamate homeostasis reported in ALS.
11357955	39	44	EAAT2	Gene	6506
11357955	83	112	amyotrophic lateral sclerosis	Disease	MESH:D000690
11357955	114	123	Glutamate	Chemical	MESH:D018698
11357955	133	147	excitotoxicity	Disease	
11357955	185	214	amyotrophic lateral sclerosis	Disease	MESH:D000690
11357955	216	219	ALS	Disease	MESH:D000690
11357955	237	246	glutamate	Chemical	MESH:D018698
11357955	259	264	EAAT2	Gene	6506
11357955	327	336	glutamate	Chemical	MESH:D018698
11357955	377	382	EAAT2	Gene	6506
11357955	558	561	ALS	Disease	MESH:D000690
11357955	562	570	patients	Species	9606
11357955	786	791	EAAT2	Gene	6506
11357955	959	962	ALS	Disease	MESH:D000690
11357955	963	971	patients	Species	9606
11357955	975	994	Alzheimer's disease	Disease	MESH:D000544
11357955	995	1003	patients	Species	9606
11357955	1293	1300	patient	Species	9606
11357955	1447	1450	ALS	Disease	MESH:D000690
11357955	1491	1494	ALS	Disease	MESH:D000690
11357955	1537	1542	EAAT2	Gene	6506
11357955	1660	1669	glutamate	Chemical	MESH:D018698
11357955	1694	1697	ALS	Disease	MESH:D000690
11357955	Association	MESH:D018698	MESH:D000690
11357955	Association	MESH:D018698	6506

